Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children

Clinical trial NCT05546502 · COMPLETED

Trial details

NCT number: NCT05546502
Sponsor: PT Bio Farma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Vaccine Reaction Vaccine Adverse Reaction

Start date: 2022-10-09
Primary completion: 2023-12-31
Enrollment: 1050

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.